It has been recently shown that OCTN1 can facilitate the intracellular accumulation of the pyrimidine nucleoside analog cytarabine, and that higher expression of OCTN1 is associated with a longer survival in patients with acute myeloid leukemia treated with this drug (Drenberg et al., 2017). The gene discussed is SLC22A4; the disease is acute myeloid leukemia.